NCT01589419 2017-11-20A Clinical Study Conducted in Multiple Centers Evaluating Escalating Doses of Veliparib in Combination With Capecitabine and Radiation in Patients With Locally Advanced Rectal CancerAbbViePhase 1 Completed32 enrolled